Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety.
Iris K MinichmayrMats O KarlssonSiv JonssonPublished in: Pharmaceutical research (2021)
The presented findings may help to avoid unfeasible trials and to rationalize the design of pharmacogenetic studies.